Most Of The US Pharmacopoeia Carries Dementia Risk With Chronic Use

Evidence is mounting that the bulk of the US pharmacopoeia full of quick fixes imposes an increased dementia risk with chronic use of the drugs (archived). At issue is the anti-cholinergic action where the problematic quick fix drugs antagonize the cholinergic nervous system. The problem spans from the seemingly innocuous over the counter antihistamines recommended for everything from allergies to a quick fix for sleep all the way to the US psycho-pharmacopoeia where nearly every drug in use carries substantial anti-cholinergic effects. Anything with a label indicating "dry mouth" as a side effect is usually going to have an anti-cholinergic effect. The association between regular use of anti-cholinergics and dementia is especially pronounced in cases where the patient with dementia is under 80 years of age.

Leave a Reply

Your email address will not be published. Required fields are marked *

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <s> <strike> <strong>